Overview
HUM market data
Price History
HUM price chart
Valuation & Profitability
- P/E (TTM)
- 36.40 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $9.83 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.76 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.9% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $163.11 – $428.88 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $46.6B · P/B 1.74 · P/S 0.32.
Company News
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFsBenzinga · Aug 14, 2026, 1:48 PM
Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’Benzinga · Aug 11, 2026, 8:28 AM
JP Morgan Maintains Neutral on Humana, Raises Price Target to $393Benzinga · Aug 10, 2026, 6:30 PM
CVRx Stock Is Falling Overnight: Here's What's Driving the MoveBenzinga · Aug 7, 2026, 5:42 AM
Independent Care Health Plan Selected By Wisconsin Department Of Health Services For Family Care, Family Care Partnership ProgramsBenzinga · Aug 5, 2026, 12:04 PM
This Humana Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For WednesdayBenzinga · Aug 5, 2026, 11:55 AM
Morgan Stanley Upgrades Humana to Equal-Weight, Raises Price Target to $370Benzinga · Aug 5, 2026, 9:33 AM
TD Cowen Maintains Hold on Humana, Raises Price Target to $370Benzinga · Jul 31, 2026, 4:45 PM
Barclays Maintains Equal-Weight on Humana, Raises Price Target to $407Benzinga · Jul 31, 2026, 11:27 AM
UBS Maintains Neutral on Humana, Raises Price Target to $405Benzinga · Jul 30, 2026, 8:38 PM